(Q48673714)

14 February 2018

reason for preferred rank

title

Reductions in acidic amino acids andN-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

28 October 2022

Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682006

amyotrophic lateral sclerosis

28 October 2022

main subject

0 references

author name string

G. C. Tsai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682006

28 October 2022

B. Stauch-Slusher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682006

28 October 2022

L. Sim

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682006

28 October 2022

J. C. Hedreen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682006

28 October 2022

J. D. Rothstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682006

28 October 2022

R. Kuncl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682006

28 October 2022

J. T. Coyle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1682006

28 October 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

14 February 2018

9 August 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1682006

full work available at URL

28 October 2022

https://api.elsevier.com/content/article/PII:000689939190560I?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

https://api.elsevier.com/content/article/PII:000689939190560I?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

28 October 2022

1 reference

14 February 2018

volume

556

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

151-156

1 reference

14 February 2018

Specific alterations in the levels of N-acetyl-aspartyl-glutamate in the nervous system of the dystrophic mouse.

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Synaptosomal transport of radiolabel from N-acetyl-aspartyl-[3H]glutamate suggests a mechanism of inactivation of an excitatory neuropeptide.

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Chemical transmission in invertebrate central nervous systems and neuromuscular junctions

28 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Degeneration of the human Betz cell due to amyotrophic lateral sclerosis

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Morphometric Comparison of the Vulnerability of Peripheral Motor and Sensory Neurons in Amyotrophic Lateral Sclerosis

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method.

28 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

N-acetylaspartic aciduria in a child with a progressive cerebral atrophy

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Protein measurement with the Folin phenol reagent

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Decrease in N-acetyl-L-aspartic acid in brain of myodystrophic mice.

28 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with canavan disease

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Metabolism of the aspartyl moiety of N-acetyl-L-aspartic acid in the rat brain.

28 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Neurochemical and immunocytochemical studies on the distribution of N-acetyl-aspartylglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Evidence for sequential degeneration of the neurons in the intermediate zone of the spinal cord in amyotrophic lateral sclerosis: a topographic and quantitative investigation

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Free amino acid levels in amyotrophic lateral sclerosis

28 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Abnormal glutamate metabolism in amyotrophic lateral sclerosis.

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application.

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

28 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Low-concentration N-acetylaspartylglutamate suppresses the climbing fiber response of Purkinje cells in guinea pig cerebellar slices and the responses to excitatory amino acids of Xenopus laevis oocytes injected with cerebellar mRNA

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Pathology of myelinated fibers in cervical and lumbar ventral spinal roots in amyotrophic lateral sclerosis

28 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Guam ALS/Parkinsonism-Dementia: A Long-Latency Neurotoxic Disorder Caused by “Slow Toxin(s)” in Food?

28 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin

28 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA.

28 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Calcium-dependent evoked release of N-[3H]acetylaspartylglutamate from the optic pathway

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

Selective release of N-acetylaspartylglutamate from rat optic nerve terminals in vivo.

28 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture

28 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0006-8993(91)90560-I

28 October 2022

Identifiers

1 reference

14 February 2018

1 reference

14 February 2018